SUMMIT PARTNERS, L.P.
SUMMIT PARTNERS, L.P. is a Pre-seed, Seed, Series A, Series B, Series C+, debt and other fund in the US and global writing $5M–$500M checks into Healthcare, technology, growth-products-services and healthcare-life-sciences.
- Stages
- Pre-seed, Seed, Series A, Series B, Series C+, debt, other
- Sectors
- Healthcare, technology, growth-products-services, healthcare-life-sciences
- Check size
- $5M–$500M
- Invests in
- US-wide, global
- Round role
- Leads rounds
- Actively investing
- Yes
- Founded
- 1984
- Assets under management
- $44B
Thesis
Summit Partners is a global investment firm founded in 1984, specializing in growth equity. Their investment strategy is flexible, taking minority and majority stakes, typically investing $10M-$500M per deal, with U.S. growth equity funds investing $75M-$500M and venture capital investments ranging from $5M-$30M. They often lead or co-lead investments, believing profitable growth is key to building durable businesses. The firm has over 200 professionals across global offices and remains active in growth equity and venture capital, despite its credit arm reportedly ceasing new investments.
Common questions
Does SUMMIT PARTNERS, L.P. invest at the Pre-seed stage?
Yes. SUMMIT PARTNERS, L.P. lists Pre-seed, Seed, Series A, Series B, Series C+, debt and other among the stages it invests in.
What check size does SUMMIT PARTNERS, L.P. write?
SUMMIT PARTNERS, L.P. writes $5M–$500M checks.
Where does SUMMIT PARTNERS, L.P. invest?
SUMMIT PARTNERS, L.P. invests in the US and global.